INFORMATIVA TITOLO Pag. 1/3 Salvo diversa indicazione, tutti i dati riportati sono aggiornati al 5.2.2018
TEVAFarmacia | Medicamentos genéricos y farmacia
A190FK | Teva Pharmaceutical Finance Netherlands II BV-Anleihe: 4,500 % bis 01.03.2025 | finanzen.net
EDM-Ahorro R FI
Condensed Interim Unaudited Financial Statements for the six month period ended 31 May 2021
Teva Pharmaceutical Industries Pharmaceutical Industry Teva Pharmaceuticals USA, Inc. Teva Canada Teva Pharmaceutical Finance Netherlands III B.V., PNG, 827x354px, Teva Pharmaceutical Industries, Biosimilar, Brand, Corporation, Generic Drug Download Free
Teva Pharmaceutical Industries LTD | PDF | Generic Drug | American Depositary Receipt
Pourquoi l'obligation Teva Pharmaceutical 3,15% 2026 bondit sur le marché secondaire | Investing.com
Company Announcement For immediate release Teva Pharmaceutical Finance Netherlands II B.V. Piet Heinkade 107, 1
Teva Pharmaceutical Finance Netherlands II B.V. (Director) - Curaçao
A1ZZHS | Teva Pharmaceutical Finance Netherlands II BV-Anleihe: 1,250 % bis 31.03.2023 | finanzen.net
Teva Pharmaceutical Finance Netherlands III B.V. Teva Pharmaceutical Finance Netherlands II B.V.
Most Active Foreign Bonds 12.05.2021 – Deutsche Telekom, Teva Pharma, Verizon, Citigroup, AMP Group, Credito Real SAB, EDF – Financial Markets Blog
Tear Sheet: Teva Pharmaceuticals Faces Pressure From Competing Generics, Seeks to Delever Quickly After Actavis Acquisition - Reorg
A1ZZHM | Teva Pharmaceutical Finance Netherlands II BV-Anleihe: 1,875 % bis 31.03.2027 | finanzen.net
Teva Announces Early Tender Results of its Debt Tender Offer, Increase of the Maximum Tender Amount and Election of Early Settlement | Business Wire
Teva Announces Launch of $4,000,000,000 Offering of Sustainability-linked Senior Notes
A1VQDB | Teva Pharmaceutical Finance Netherlands II BV-Anleihe: 1,625 % bis 15.10.2028 | finanzen.net
printmgr file
PFA Pension, erhvervsobligationer
UNITED STATES SECURITIES AND EXCHANGE COMMISSION FORM 20-F TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Teva Pharmaceutical Industries. Information about the issuer. (LEI 549300BAFGM4RC74ZJ94, SWIFT TEVPILITXXX). News and credit ratings. Tables with accounting and financial reports.
Teva Pharmaceutical Finance Netherlands II BV 3,15% 01/10/2026 USD | OBLIS
Teva Pharmaceutical Industries Ltd SEC Registration
